Form 4: Azenta Executive Ephraim Starr Granted Over 37,000 Restricted Stock Units

Azenta, Inc.'s SVP, General Counsel & Secretary, Ephraim Starr, was granted 37,779 restricted stock units (RSUs) valued at $26.71 per unit, vesting over three years.

Summary

• Ephraim Starr, SVP, General Counsel & Secretary of Azenta, Inc. (AZTA), acquired 37,779 shares of common stock.
• The transaction occurred on May 15, 2025, and represents a grant of restricted stock units (RSUs) under the company's Equity Incentive Plan.
• The RSUs were granted at a price of $26.71 per unit, with no amount paid by the reporting person upon grant.
• The total value of the RSU grant at the time of transaction was approximately $1,008,000.09 (37,779 units * $26.71/unit).
• These units will vest over a three-year period, with 33% vesting on May 15, 2026, 33% on May 15, 2027, and the remaining 33% on May 15, 2028.
• Following this transaction, Ephraim Starr directly beneficially owns 37,779 shares of common stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a key executive is generally a positive sign, indicating alignment of interests and a commitment to long-term retention. It does not, however, provide direct insight into the company's operational or financial performance.

Positives

• The grant of restricted stock units aligns the executive's interests with those of shareholders, incentivizing long-term performance and retention.
• The equity incentive plan demonstrates the company's commitment to compensating and retaining key management personnel.

Negatives

• No direct negatives are indicated in this Form 4 filing, as it reports a standard equity compensation grant.

Risks

• The value of the granted restricted stock units is subject to the future performance of Azenta, Inc.'s stock price, meaning the actual realized value could be lower than the grant date value.
• The vesting schedule ties the executive's compensation to continued employment, which could be a risk if the executive departs before full vesting.

Future Outlook

This Form 4 filing does not provide a future outlook for Azenta, Inc.'s business operations or financial performance. It solely reports an insider's equity transaction.

Industry Context

This filing is a routine disclosure of an executive's equity compensation, common across all industries for publicly traded companies. It reflects standard practices for incentivizing management through long-term equity awards.

Comparison to Industry Standards

• The grant of restricted stock units with a multi-year vesting schedule is a common form of long-term incentive compensation for executives in the technology and life sciences sectors, aligning with industry standards for executive retention and performance alignment.
• The specific number of units and their value would typically be benchmarked against peer companies of similar size and market capitalization within the life sciences tools and services industry, such as Danaher Corporation (DHR), Thermo Fisher Scientific Inc. (TMO), or Sartorius AG (SRT.DE), to ensure competitive compensation.

Related Party Transactions

• The grant of restricted stock units to Ephraim Starr, an executive officer, is a transaction between the company and a related party (insider) as part of an approved equity incentive plan.

Stakeholder Impact

• Shareholders: The grant aligns the executive's financial interests with long-term shareholder value creation, as the value of the RSUs is tied to the company's stock performance.
• Employees: This type of compensation can serve as a model for broader employee incentive programs, potentially boosting morale and retention across the organization.
• Management: Provides a significant long-term incentive for Ephraim Starr to contribute to the company's success and remain with Azenta, Inc.

Next Steps

• The granted restricted stock units will vest in three annual installments, with the first vesting on May 15, 2026, the second on May 15, 2027, and the final on May 15, 2028.

Key Dates

Keywords

Azenta Inc., AZTA, Form 4, SEC filing, restricted stock units, RSU grant, insider transaction, equity compensation, Ephraim Starr, SVP General Counsel, beneficial ownership